Ampyra and Centrum silver drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ampyra (dalfampridine) and Centrum silver (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e). Common drug interactions include asthenia among females and drug ineffective among males.
The phase IV clinical study analyzes what interactions people have when they take Ampyra and Centrum silver. It is created by eHealthMe based on reports of 284 people who take the same drugs from the FDA, and is updated regularly.
What is Ampyra?
Ampyra has active ingredients of dalfampridine. It is often used in multiple sclerosis. eHealthMe is studying from 77,145 Ampyra users. Check the latest studies of Ampyra.
What is Centrum silver?
Centrum silver has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is often used in vitamin supplementation. eHealthMe is studying from 19,997 Centrum silver users. Check the latest studies of Centrum silver.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
284 people who take Ampyra and Centrum silver together, and have interactions are studied.
What are the common drug interactions of Ampyra and Centrum silver, by gender? *
What are the common drug interactions of Ampyra and Centrum silver, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Ampyra and Centrum silver?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ampyra (77,145 reports)
- Centrum silver (19,997 reports)
Browse all drug interactions of Ampyra and Centrum silver:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ampyra:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Centrum silver:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ampyra and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Centrum silver and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on dalfampridine and ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e (the active ingredients of Ampyra and Centrum silver, respectively), and Ampyra and Centrum silver (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Adcal and Hypotension Aggravated for Women aged 60+ - 10 seconds ago
- Could Creon cause Bronchopulmonary Aspergillosis? - 37 seconds ago
- Pravachol and Tendon Disorder for Women aged 60+ - 38 seconds ago
- Rhinocort and Lymphadenopathy for Women aged 60+ - 46 seconds ago
- Rhinocort and Lymph Follicular Hypertrophy for Women aged 60+ - 47 seconds ago
- Could Warfarin Sodium cause Radiculitis Cervical? - 57 seconds ago
- How effective is Probiotic for Digestive? - a minute ago
- Eliquis and Rozerem drug interactions for men aged 60+ - a minute ago
- Prograf and Rheumatoid Arthritis Aggravated for Women aged 40-49 - a minute ago
- Aprepitant and Spironolactone drug interactions for men aged 50-59 - a minute ago